Outset Medical, Inc. (OM) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$3.99

From 52W high−75.53%

Volume59182.00

Market cap$71.43M

P/E (TTM)—

P/S (TTM)0.6x

Div yield—

Key dataOct 19, 2026

Open

$3.99

From 52W high

−75.53%

Volume

59182.00

Market cap

$71.43M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.5x

P/E (TTM)

—

RSI (14)

52.8

MomentumView details →

1D Return

−3.55%

YTD Return

+4.31%

SummaryUpdated Jun 1, 2026

Outset Medical, Inc. (NASDAQ:OM) is a medical technology company founded in 2003 and headquartered in San Jose, California. Originally incorporated as Home Dialysis Plus, Ltd., the company changed its name to Outset Medical in January 2015 and went public in September 2020. Outset has developed an innovative hemodialysis system designed to transform kidney dialysis treatment by making it more accessible and cost-effective across multiple care settings, including hospitals, outpatient centers, and patients' homes.

Ask drillr about Outset Medical, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.5x

EV/Sales

0.2x

P/S (TTM)

0.6x

P/B (TTM)

0.7x

ProfitabilityView details →

Gross Margin

41.76%

Net Margin

−63.06%

EBITDA Margin

−48.39%

ROE (TTM)

−77.12%

ROA (TTM)

−30.65%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

−1.26%

EPS YoY

+83.05%

FCF YoY

+43.16%

Revenue CAGR 3Y

+1.17%

EPS CAGR 3Y

+85.47%

EBITDA YoY

+14.76%

MomentumView details →

1D Return

−3.55%

YTD Return

+4.31%

1Y Return

−75.08%

RSI (14)

52.8

vs 50D SMA

+2.23%

vs 200D SMA

−7.23%

Capital & dividendView details →

Debt/Equity

1.08x

Current Ratio

5.19x

Quick Ratio

4.11x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.80

EPS Surprise

−11.63%

Beats (12Q)

5/12

Next Q EPS Est

−$0.69

Avg Surprise (4Q)

−26.88%

Rev Surprise

9.21%

Financials snapshotView financials →

Revenue (TTM)

117.80M

Net Income (TTM)

−74.29M

Op. CF (TTM)

−38.32M

Next earningsNov 9, 2026 →

Latest newsMore news →

Outset Medical CFO Renee Gaeta sold 4,543 shares of company stock on August 17, 2026, to cover tax withholding obligations from RSU vesting.62d ago

Outset Medical announced a new $40 million refresh agreement with HCA Healthcare.74d ago

Similar companies

Lucid Diagnostics Inc.LUCD LENSAR, Inc.LNSR electroCore, Inc.ECOR Pulmonx CorporationLUNG Hyperfine, Inc.HYPR Envoy Medical, Inc.COCH Find similar companies →

Latest newsMore news →

Outset Medical CFO Renee Gaeta sold 4,543 shares of company stock on August 17, 2026, to cover tax withholding obligations from RSU vesting.62d ago Outset Medical announced a new $40 million refresh agreement with HCA Healthcare.74d ago